Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

56.39
Delayed Data
As of Jul 21
 +0.53 / +0.95%
Today’s Change
24.58
Today|||52-Week Range
57.77
+17.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Operating ActivitiesNet Income / Starting Line-56.9M7.4M25.9M3.5M
 
 
 
 
 
Depreciation2.3M2.3M2.3M2.4M
 
 
 
 
 
Total Other Cash Flow29.0M27.8M29.9M31.8M
 
 
 
 
 
Funds From Operations-25.6M37.4M58.0M37.7M
 
 
 
 
 
Funds From/For Other Operating Expenses8.2M14.0M84.0M-85.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-33.8M23.4M-26.0M122.7M
 
 
 
 
 
 
InvestingIncrease In Investments-40.4M-152.7M-66.4M-266.2M
 
 
 
 
 
Decrease In Investments98.4M97.8M91.1M101.7M
 
 
 
 
 
Capital Expenditures-4.4M-2.2M-3.8M-4.2M
 
 
 
 
 
Net Cash Flow Investing53.5M-57.1M20.8M-168.7M
 
 
 
 
 
 
FinancingShort Term Borrowings----0.00----
Long Term Borrowings----0.00----
Long Term Debt Reduction-1.9M-1.7M-1.6M-1.6M
 
 
 
 
 
Net Proceeds Stock Sale1.4M3.1M5.3M77.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.001.9M0.00
 
 
Other Uses - Financing0.000.00--0.00--
Net Cash Flow - Financing-476.0K5.4M5.6M75.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash19.2M-28.3M410.0K29.5M